Nav: Home

Tapeworm vaccine gets US $200,000 funding boost

December 17, 2015

Professor Marshall Lightowlers, from the Faculty of Veterinary and Agricultural Sciences, is the principal investigator for a US$200,000 (A$272,000) grant from the Bill & Melinda Gates Foundation for his work on a Taenia solium vaccine.

T. solium is a worm parasite that is transmitted between humans and pigs and causes neurocysticercosis, or brain cysts, in human hosts.

It is the cause of an estimated 50,000 deaths each year, most prevalent in developing countries across Africa, China, Central and South America and South-East Asia, where hygiene standards are lax and unregulated.

"This grant will go a long way to helping us develop a one-shot vaccine that will break the lifecycle of this harmful parasite, which is the most frequent cause of late onset seizures and epilepsy in the developing world," Professor Lightowlers said.

"We hope to change that."

The University of Melbourne has already developed a vaccine for use in pigs against infection from T. solium, which is on the brink of becoming commercially available as of next year.

But to be successful, the vaccine requires two immunisations.

That's a near-to-impossible feat in countries where pig communities are free-roaming and not closely monitored.

The Gates Foundation grant runs over two years, with MIT to test vaccine formulations and forward them on to the University of Melbourne for clinical trials.

The T. solium parasite and neurocysticercosis were once endemic throughout Europe and other developed parts of the world, but improved public sanitation and other measures saw it eventually eliminated.

Professor Lightowlers said a vaccine could potentially do the same for the world's developing nations within our lifetime.

But first-world countries are still not immune to the effects.

Professor Lightowlers highlighted an example of an orthodox Jewish family, from which two members were diagnosed with larvae of a pork tapeworm in their brains. It was later found that a domestic employee from Mexico with a T. solium infection had unintentionally contaminated the family's food during preparation.

"Keep in mind that people from poor countries can travel anywhere with their intestinal residents and deliver their tapeworm eggs to you or me," he said.

"So it is vital in the global sense to see a reduction in the parasite's transmission."

In endemic areas, the T. solium parasite is associated with 29 percent of people with epilepsy, making it the most frequent cause of seizure disorders.

University of Melbourne

Related Epilepsy Articles:

Good news for kids with epilepsy
There's good news for kids with epilepsy. While several new drugs have come out in the last several years for adults with epilepsy, making those drugs available for children and teenagers has been delayed due to the challenges of testing new drugs on children.
People with epilepsy: Tell us about rare risk of death
People with epilepsy want their health care providers to tell them about a rare risk of death associated with the disorder, according to a preliminary study released today that will be presented at the American Academy of Neurology's 69th Annual Meeting in Boston, April 22 to 28, 2017.
New epilepsy gene network identified by scientists
Scientists have discovered a gene network in the brain associated with epilepsy.
Epilepsy -- why do seizures sometimes continue after surgery?
New research from the University of Liverpool, published in the journal Brain, has highlighted the potential reasons why many patients with severe epilepsy still continue to experience seizures even after surgery.
Redox biomarker could predict progression of epilepsy
Approximately 2.9 million people in the United States suffer from epilepsy, according to the CDC.
Many Malaysian children with epilepsy are vitamin D deficient
Long-term use of antiepileptic drugs is a significant risk factor for vitamin D deficiency in children with epilepsy.
Changes in heart activity may signal epilepsy
Researchers at Case Western Reserve University have found that the parasympathetic nervous system modulates breathing and slows the heart rate of sleeping children with epilepsy substantially more than in healthy children.
Few answers in understanding death from epilepsy
To increase understanding of mortality in epilepsy, including SUDEP, Partners Against Mortality in Epilepsy (PAME) unites physicians, scientists, health care professionals, people with epilepsy, caregivers and bereaved family members for a unique conference that facilitates collaboration and spurs action.
New insights into epilepsy drug Retigabine
A study published ahead of print in the Journal of General Physiology has revealed new insights into Retigabine, a known pharmacological treatment for epilepsy.
Are women with epilepsy using effective contraception?
In the largest study of contraceptive practices of women with epilepsy, 30 percent did not use highly effective contraception despite being at higher risk of having children with fetal malformations due to the anti-epilepsy medications they take.

Related Epilepsy Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...